Current Position President and CEO, Organogenesis Inc. Place and Date of Birth Montreal; April 28, 1966 Education B.A., Cert. Marketing, McGill University The Qualities That Inspire Him The most inspiring people combine talent with emotional intelligence and strong communication skills Person Who Has Inspired Him His mother inspired him the most in life; she was an athlete who competed at the national and international level in multiple sports for Canada, she not only infected him with a strong dose of competitive drive, but also taught him how to laugh and enjoy himself along the way

Media Coverage : Articles

Geoff Mackay Featured as One of the Top 100 Most Inspiring People

Building on People Power

July/August, 2007

People first, business second is the approach Geoff Mackay has taken to building a strong company.

His methods are paying off; Mr. Mackay also was a 2006 PharmaVOICE 100 honoree.

By creating an atmosphere where people want to do well and produce more than what is expected of them, Mr. Mackay has turned Organogenesis into a leader in the wound-care arena and built a great team of executives.

Mr. Mackay helps guide his staff both through his actions, moving quickly to act on a problem when needed, and by posing questions that encourage critical thinking. A great listener, Mr. Mackay is easily approachable and combines an innovative approach to business with a deep-seated compassion for patients.

As a leader in regenerative medicines, Mr. Mackay paints the picture of how the world will look when living, cell-based products are truly a standard of care for patients. And he recognizes that for Organogenesis to be the company to make this happen, it will be critical to constantly identify the unique skill sets that are required to succeed. Far from finding this prospect daunting, Mr.Mackay believes nothing can be more fun and satisfying than building the company's competencies to change the practice of medicine.

Already, the company has made huge inroads into defining the field, firstly, by achieving the first FDA approval of a living cell therapy, and secondly, by creating the first profitable business model that mass-produces living-cell therapies on demand for medical clinics around the world. Mr. Mackay is extremely proud of the fact that more than two-thirds of all patients who have received a living, cell-based product are Organogenesis patients. These accomplishments have helped to transition regenerative medicine from brilliant Petri dish-type basic research into a commercial reality that impacts patients' lives.

Once floundering in bankruptcy, Organogenesis has enjoyed 35% growth per annum under Mr. Mackay's stewardship. His broad and deep knowledge of the international business arena has helped the company grow as well as establish relationships with clients and business partners.

In June, Organogenesis announced a doubling of its employee numbers from 300 to 600. To accommodate the company's substantial growth, the company initiated a major project to build the world's first state-of-the-art, automated cell-therapy manufacturing facility in Massachusetts. For Mr. Mackay and his staff, announcing the major expansion side-by-side with the state's Governor Deval Patrick was the culmination of many years of hard work.

Mr. Mackay's goal is to triple revenue of the company's flagship product, Apligraf^®, over the next five years and launch multiple innovative cell-based products.The company recently opened a European head office and is eager to replicate its U.S. success abroad.

» Back to Media Coverage